J. Ferlay, I. Soerjomataram, M. Ervik, R. Dikshit, S. Eser et al., Cancer Incidence and Mortality Worldwide: IARC CancerBase, issue.11, 2012.

F. Lyon, (2) International Agency for Research on Cancer, 2013.

M. Sant, C. Lopez, M. D. Agresti, and R. , Survival of women with cancers of breast and genital organs in Europe 1999-2007: results of the EUROCARE-5 study, Eur J Cancer, vol.51, pp.2191-2205, 2015.

, Données par localisation. Cancer du col de l'utérus. Publié le 01/02/2017. Date de dernière mise

J. M. Walboomers, M. V. Jacobs, M. M. Manos, F. X. Bosch, J. A. Kummer et al., Human papillomavirus is a necessary cause of invasive cervical cancer worldwide, J Pathol, vol.189, pp.12-19, 1999.

H. Rakotomahenina, C. Bonneau, R. Ramanah, R. Rouzier, J. L. Brun et al., , vol.11, pp.1-12, 2016.

, Vaccination anti-HPV et cancer du col de l'utérus. Date de dernière mise à jour : 04/07, 2018.

L. Fonteneau, J. P. Guthmann, and D. Lévy-bruhl, Estimation des couvertures vaccinales en France à partir de l'Échantillon généraliste des bénéficiaires (EGB) : exemples de la rougeole, de l'hépatite B et de la vaccination HPV, Bulletin Epidemiol Hebd, vol.8, issue.9, pp.72-76, 2013.

, Portugal : couvertures vaccinales en 2014 des jeunes filles de 14 ans -vaccination de routine à 13 ans

, QFjAA&url=http%3A%2F%2Fwww.dgs.pt%2Fem-destaque%2Fboletim-de-vacinacao-n9-abril-2015-pdf.aspx&ei=B2KRVefOA8ScygOu14D4CQ&usg=AFQjCNFvF0EXrQPeiCWXLrdUxC153u_0ZQ &bvm=bv.96783405,d.bGQ

R. Uni, Department of health (DoH) HPV coverage monitoring, Couvertures vaccinales à 12-13 ans en 2013-2014

H. Ali, B. Donovan, H. Wand, T. R. Read, D. G. Regan et al., Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data, BMJ, vol.8, p.2032, 2013.

, Dépistage du cancer du col de l'utérus. Date de dernière mise à jour le 30/05, 2018.

, État des lieux et recommandations pour le dépistage du cancer du col de l'utérus en France, Juillet, 2010.

S. S. Wang, M. E. Sherman, A. Hildesheim, J. V. Lacey, and S. Devesa, Cervical adenocarcinoma and squamous cell carcinoma incidence trends among white women and black women in the United States for, Cancer, vol.100, pp.1035-1044, 1976.

L. G. Koss, The Papanicolaou test for cervical cancer detection. A triumph and a tragedy, JAMA, vol.261, pp.737-743, 1989.

A. N. Rosenthal, T. Panoskaltsis, T. Smith, and W. P. Soutter, The frequency of significant pathology in women attending a general gynaecological service for postcoital bleeding, BJOG, vol.108, pp.103-106, 2001.

R. Pretorius, N. Semrad, W. Watring, and N. Fotheringham, Presentation of cervical cancer, Gynecol Oncol, vol.42, pp.48-53, 1991.

, Données issues du Registre des tumeurs de l'Hérault et de l'étude Pétri

K. Hellman, A. C. Hellström, and B. F. Pettersson, Uterine cervix cancer treatment at Radiumhemmet: 90 years' experience. Time trends of age, stage, and histopathology distribution, Cancer Med, vol.3, pp.284-292, 2014.

P. Loubeyre, I. Navarria, M. Undurraga, A. Bodmer, O. Ratib et al., Is imaging relevant for treatment choice in early stage cervical uterine cancer?, Surg Oncol, vol.21, pp.1-6, 2012.

S. H. Choi, S. H. Kim, H. J. Choi, B. K. Park, and H. J. Lee, Preoperative magnetic resonance imaging staging of uterine cervical carcinoma: results of prospective study, J Comput Assist Tomogr, vol.28, pp.620-627, 2004.

S. Marnitz, C. Köhler, S. Bongardt, U. Braig, H. Hertel et al., Topographic distribution of sentinel lymph nodes in patients with cervical cancer. German Association of Gynecologic Oncologists (AGO), Gynecol Oncol, vol.103, pp.35-44, 2006.

C. H. Lai, J. H. Hong, S. Hsueh, K. K. Ng, T. C. Chang et al., Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases, Cancer, vol.85, pp.1537-1546, 1999.

S. M. Kim, H. S. Choi, and J. S. Byun, Overall 5-year survival rate and prognostic factors in patients with stage IB and IIA cervical cancer treated by radical hysterectomy and pelvic lymph node dissection, Int J Gynecol Cancer, vol.10, pp.305-312, 2000.

H. J. Choi, W. Ju, S. K. Myung, and Y. Kim, Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: meta-analysis, Cancer Sci, vol.101, pp.1471-1479, 2010.

H. H. Chou, H. P. Chang, C. H. Lai, K. K. Ng, S. Hsueh et al., )F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma, Eur J Nucl Med Mol Imaging, vol.37, issue.18, pp.728-735, 2010.

K. Kitajima, K. Suzuki, M. Senda, M. Kita, Y. Nakamoto et al., Preoperative nodal staging of uterine cancer: is contrast-enhanced PET/CT more accurate than non-enhanced PET/CT or enhanced CT alone?, Ann Nucl Med, vol.25, pp.511-519, 2011.

S. Gouy, P. Morice, F. Narducci, C. Uzan, J. Gilmore et al., Nodal-staging surgery for locally advanced cervical cancer in the era of PET, Lancet Oncol, vol.13, pp.212-220, 2012.

, Guide ALD 30 cancer invasif du col utérin, Haute Autorité de Santé (HAS), 2010.

. Société-française-d'oncologie-gynécologique, Référentiel de traitement des cancers du col utérin de type hystologique épidermoïde et adénocarcinome. Mars, 2016.

E. Leblanc, F. Narducci, M. Frumovitz, A. Lesoin, B. Castelain et al., Therapeutic value of pretherapeutic extraperitoneal laparoscopic staging of locally advanced cervical carcinoma, Gynecol Oncol, vol.105, pp.304-311, 2007.

G. Cartron, E. Leblanc, G. Ferron, P. Martel, F. Narducci et al., Complications of laparoscopic lymphadenectomy in gynaecologic oncology. A series of 1102 procedures in 915 patients, Gynecol Obstet Fertil, vol.33, pp.304-314, 2005.

P. Benedetti-panici, F. Maneschi, G. Scambia, S. Greggi, G. Cutillo et al., Lymphatic spread of cervical cancer: an anatomical and pathological study based on 225 radical hysterectomies with systematic pelvic and aortic lymphadenectomy, Gynecol Oncol, vol.62, pp.19-24, 1996.

N. Sakuragi, Up-to-date management of lymph node metastasis and the role of tailored lymphadenectomy in cervical cancer, Int J Clin Oncol, vol.12, pp.165-75, 2007.

V. Lavoue, A. S. Bats, and E. Darai, Pelvic and para-aortic lymphadenectomy are required to stage locally advanced cervical cancer, Gynecol Oncol, vol.109, pp.427-428, 2008.

G. Houvenaeghel, L. Lelievre, A. L. Rigouard, M. Buttarelli, J. Jacquemier et al., Residual pelvic lymph node involvement after concomitant chemoradiation for locally advanced cervical cancer, Gynecol Oncol, vol.102, pp.74-79, 2006.

, (38) National Cancer Institute. Cervical Cancer Treatment, NCCN Clinical Guideline in Oncology. Cervical Cancer, 2014.

N. Colombo, S. Carinelli, A. Colombo, C. Marini, D. Rollo et al., Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann Oncol Off J Eur Soc Med Oncol, vol.23, pp.27-32, 2012.

, AGO. Cervical carcinoma, 2014.

S. Nagase, Y. Inoue, N. Umesaki, D. Aoki, M. Ueda et al., Evidence-based guidelines for treatment of cervical cancer in Japan: Japan Society of Gynecologic Oncology (JSGO) 2007 edition, Int J Clin Oncol, vol.15, pp.117-141, 2010.

C. W. Whitney, W. Sause, B. N. Bundy, J. H. Malfetano, E. V. Hannigan et al., Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stage IIB-IVA carcinoma of the cervix with negative paraaortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study, J Clin Oncol, vol.17, pp.1339-1348, 1999.

P. G. Rose, B. N. Bundy, E. B. Watkins, J. T. Thigpen, G. Deppe et al., Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer, N Engl J Med, vol.340, pp.1144-1153, 1999.

M. Morris, P. J. Eifel, J. Lu, P. W. Grigsby, C. Levenback et al., Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer, N Engl J Med, vol.340, pp.1137-1143, 1999.

H. M. Keys, B. N. Bundy, F. B. Stehman, L. I. Muderspach, W. E. Chafe et al., Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma, N Engl J Med, vol.340, pp.1154-1161, 1999.

. Peters-wa-3-rd, P. Y. Liu, . Barrett-rj-2-nd, R. J. Stock, B. J. Monk et al., Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix, J Clin Oncol, vol.18, pp.1606-1613, 2000.

H. M. Keys, B. N. Bundy, F. B. Stehman, T. Okagaki, D. G. Gallup et al., Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the gynecologic oncology group, Gynecol Oncol, vol.89, pp.343-53, 2003.

J. M. Classe, P. Rauch, J. F. Rodier, P. Morice, E. Stoeckle et al., Surgery after concurrent chemoradiotherapy and brachytherapy for the treatment of advanced cervical cancer: morbidity and outcome: results of a multicenter study of the GCCLCC (groupe des chirurgiens de centre de lutte contre le cancer), Gynecol Oncol, vol.102, pp.523-529, 2006.

V. Lavoué, L. Voguet, C. Bertel, H. Mesbah, D. Williaume et al., Place de la chirurgie avant et après radiochimiothérapie des cancers du col localement évolués : à propos de 102 cas, Journal de Gynecologie Obstetrique et Biologie de la Reproduction, vol.40, pp.11-21, 2011.

C. Touboul, C. Uzan, A. Mauguen, S. Gouy, A. Rey et al., Morbidité de la chirurgie de clôture après radio-chimiothérapie chez des patientes atteintes d'un cancer du col de stade avancé, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, vol.39, pp.624-631, 2010.

P. E. Colombo, M. M. Bertrand, M. Gutowski, A. Mourregot, M. Fabbro et al., Total laparoscopic radical hysterectomy for locally advanced cervical carcinoma (stages IIB, IIA and bulky stages IB) after concurrent chemoradiation therapy: Surgical morbidity and oncological results, Gynecol Oncol, vol.114, pp.404-409, 2009.

, Neoadjuvant Chemotherapy for Locally Advanced Cervical Cancer Meta-analysis Collaboration et al. Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and metaanalysis of individual patient data from 21 randomised trials, Eur J Cancer, vol.39, pp.2470-2486, 2003.

L. Rydzewska, J. Tierney, C. L. Vale, and P. R. Symonds, Neoadjuvant chemotherapy plus surgery versus surgery for cervical cancer, Cochrane Database Syst Rev, vol.12, p.7406, 2012.

, European Organisation for Research and Treatment of Cancer -EORTC. Chemotherapy followed by surgery vs radiotherapy plus chemotherapy in patients with stage Ib or II cervical cancer, EORTC Protocol, vol.55994

H. E. Averette, D. M. Donato, J. L. Lovecchio, and B. U. Sevin, Surgical staging of gynecologic malignancies, Cancer, vol.60, pp.2010-2020, 1987.

C. H. Lai, K. G. Huang, J. H. Hong, C. L. Lee, H. H. Chou et al., Randomized trial of surgical staging (extraperitoneal or laparoscopic) versus clinical staging in locally advanced cervical cancer, Gynecol Oncol, vol.89, pp.160-167, 2003.

M. A. Gold, C. Tian, C. W. Whitney, P. G. Rose, and R. Lanciano, Surgical versus radiographic determination of para-aortic lymph node metastases before chemoradiation for locally advanced cervical carcinoma: a Gynecologic Oncology Group Study, Cancer, vol.112, pp.1954-1963, 2008.

S. Marnitz, C. Köhler, C. Roth, J. Füller, W. Hinkelbein et al., Is there a benefit of pretreatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?, Gynecologic Oncology, vol.99, pp.536-544, 2005.

R. Rouzier, P. Morice, D. Crevoisier, R. Pomel, C. Rey et al., Survival in cervix cancer patients treated with radiotherapy followed by radical surgery, Eur J Surg Oncol, vol.31, pp.424-433, 2005.

Y. Sonoda, E. Leblanc, D. Querleu, B. Castelain, T. H. Papageorgiou et al., Prospective evaluation of surgical staging of advanced cervical cancer via a laparoscopic extraperitoneal approach, Gynecol Oncol, vol.91, pp.326-331, 2003.

D. Querleu, Pelvic lymph node dissection via a lateral extraperitoneal approach: description of a technique, Gynecol Oncol, vol.109, pp.81-85, 2008.

S. Gouy, Single-port laparoscopy and extraperitoneal para-aortic lymphadenectomy, Gynecol Oncol, vol.123, pp.329-332, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00880361

F. Narducci, Early experience of robotic-assisted laparoscopy for extraperitoneal para-aortic lymphadenectomy up to the left renal vein, Gynecol Oncol, vol.115, pp.172-174, 2009.

E. Leblanc, F. Narducci, S. Gouy, P. Morice, G. Ferron et al., Lymphadénectomies laparascopiques dans les cancers gynécologiques, EMC -Techniques Chirurgicales -Gynécologie, vol.8, pp.1-15, 2013.

M. Mikami, Y. Aoki, M. Sakamoto, M. Shimada, N. Takeshima et al., Surgical Principles for Managing Stage IB2, IIA2, and IIB Uterine Cervical Cancer (Bulky Tumors) in Japan, Int J Gynecol Cancer, vol.24, pp.1333-1340, 2014.

P. Morice, P. Rouanet, A. Rey, P. Romestaing, G. Houvenaeghel et al., Results of the GYNECO 02 Study, an FNCLCC Phase III Trial Comparing Hysterectomy with No Hysterectomy in Patients with a (Clinical and Radiological) Complete Response After Chemoradiation Therapy for Stage IB2 or II Cervical Cancer, The Oncologist, vol.17, pp.64-71, 2012.
URL : https://hal.archives-ouvertes.fr/hal-00873869

V. Lavoué, L. Voguet, C. Bertel, H. Mesbah, D. Williaume et al., Place de la chirurgie avant et après radiochimiothérapie des cancers du col localement évolués : à propos de 102 cas, Journal de Gynécologie Obstétrique et Biologie de la Reproduction, vol.40, pp.11-21, 2001.

D. Mariagrazia, A. F. Gabriella, F. , F. F. , D. S. Giuseppe et al., Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications, Gynecol Oncol, vol.99, pp.166-170, 2005.

E. Azria, P. Morice, C. Haie-meder, A. Thoury, P. Pautier et al., Results of hysterectomy in patients with bulky residual disease at the end of chemoradiation therapy for stage IB2/II cervical carcinoma, Ann Surg Oncol, vol.12, pp.332-337, 2005.

G. Houvenaeghel, L. Lelievre, M. Butarelli, J. Jacquemier, X. Carcopino et al., Contribution of surgery in patients with bulky residual disease after chemoradiation for advanced cervical carcinoma, Eur J Surg Oncol, vol.33, pp.498-503, 2007.

E. Vincens, C. Balleyguier, A. Rey, C. Uzan, E. Zareski et al., Accuracy of magnetic resonance imaging in predicting residual disease in patients treated for stage IB2/II cervical carcinoma with chemoradiation therapy : correlation of radiologic findings with surgicopathologic results, Cancer, vol.113, pp.2158-65, 2008.

J. E. Mongula, F. Bakers, S. Vöö, L. Lutgens, T. Van-gorp et al., Positron emission tomography-magnetic resonance imaging (PET-MRI) for response assessment after radiation therapy of cervical carcinoma: a pilot study

J. S. Frenel, L. Tourneau, C. , O. Neil, B. Ott et al., Safety and Efficacy of Pembrolizumab in Advanced, Programmed Death Ligand 1-Positive Cervical Cancer: Results From the Phase Ib KEYNOTE-028 Trial, J Clin Oncol, vol.35, pp.4035-4041, 2017.

S. Lheureux, M. O. Butler, B. Clarke, M. C. Cristea, L. P. Martin et al., Association of ipilimumab with safety and antitumor activity in women with metastatic or recurrent human papillomavirus-related cervical carcinoma, JAMA Oncol, vol.4, pp.173-776, 2018.

, Annexe 1

, Classification des cancers du col utérin selon la Fédération International de Gynécologie et d'Obstétrique (FIGO), 2009.

, Annexe 2

, Algorithme de prise en charge des cancers du col utérin à un stade localement avancé